Analysts/Institutional Investor Meet/Con. Call Updates

Date: July 27, 2026 To, To, Sr. General Manager Sr. General Manager BSE Limited National Stock Exchange of India Limited Listing Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Sub.: Audio recording of Earnings Conference Call for the quarter ended June 30, 2026 Dear Sir/Madam, In compliance with Regulations 30 and 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (w“eF ihnearnecbiya li nRfeosruml ttsh”a)t the Company had Earnings Conference Call with several Analysts/Institutional Investors/Funds and other investors on the Unaudited Financial Results of the Company for the quarter ended June 30, 2026 on July 27, 2026. The audio recording of said Earnings Conference Call of the Company held today i.e., Monday, July 27, 2026 is available on the website of the Company and can be accessed at the weblink: https://senorespharma.com/investor-meet/. No Unpublished Price Sensitive Information was shared/discussed by the Company during the Earnings Conference Call. You are requested to take the same on record. TFohra nSkeinnogr yeosu P. harmaceuticals Limited Deval Rajnikant Shah Whole Time Director & CFO DIN: 00332722 Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263